EMCDDA Home
  • EN
Search

Table PPP-8. Purity of synthetic drugs at retail level, 2011

Part (iii) Geographical coverage / sampling frame / type of study

CountryGeographical coverage / Sampling frame / Type of study
BelgiumNational / seizures sent to the laboratories for analysis following prosecutors' decision / analysis developed by 11 laboratories including data from "Project drugs in circulation"
BulgariaNational / all seizures / routine analysis of seizures. Adulterants/cutting agents/impurities in amphetamine and MDMA samples: Amphetamine: caffeine, quinine, paracetamol and theophiline; MDMA: caffeine and lactose
Czech RepublicNational / all seizures / routine analysis of seizures in some laboratories; not all analysis and all laboratories are included (permanent data collection twice per year).
Denmark-ANational (5 largest cities ) / small seizures at user's level, random selection of powder between 0,03 and 1 gram in the 5 largest cities/ monitoring system / base
Denmark-BNational / all police seizures / monitoring system / base
GermanyNational / all seizures linked to criminal investigation / routine analysis of seizures / base
EstoniaNational / all seizures / routine analysis of seizures
FranceNational / all seizures / monitoring system
ItalyNational / seizures under a specific threshold (Latium all seizures) / routine analysis of seizures
LatviaNational / all seizures / routine analysis of seizures
LithuaniaNational / all seizures - amphetamine purity refer to amphetamine powder only / routine analysis of seizures
LuxembourgNational / all seizures random sampling / monitoring system
HungaryNational / all seizures submitted for analysis of over: 0.7g for amphetamines, 10 units for ecstasy, and less than 100g for 'street level' powders / routine analysis of seizures
MaltaNational / random sample of police and customs seizures / monitoring system
NetherlandsNational / all samples provided by drug users containing at least 1 mg of the substance (1011 samples were purchased as amphetamine, 8 as methamphetamine and 2357 as MDMA) / routine analysis of drug samples provided by users
AustriaNational / seizures under a specific threshold / seizures when suspicion about the substance / test purchases at street level / routine analysis of seizures
PolandNational / samples at user's level / routine analysis of seizures
PortugalNational / random selected sample of seizures of under 1 g / routine analysis of seizures
RomaniaNational / sampling of all cases (retail or large) for which the authorities requested the potency analysis according UNODC best practice manual / routine analysis of seizures / salt for MDMA; base for amphetamine (using gas chromatography with flame ionization detection (GC-FID) technique)
SloveniaNational / all seizures. Ecstasy sample size is based on logos / routine analysis of seizures
SlovakiaNational / all seizures / routine analysis of seizures / base
Finland:
SwedenNational / seizures made by the police. Quantitative analysis is always carried out on seizures consisting of >200g or on request from the police / Data is collected continuously throughout the year
United KingdomNational (England and Wales) / no more than 25 g seizures submitted for analysis by police forces / routine analysis of seizures / base
CroatiaNational / all seizures / routine analysis of seizures
TurkeyNational / seizures sent to the laboratories for analysis due judicial or law enforcement needs / routine analysis of seizures
NorwayNational / all seizures / routine analysis of seizures
 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013